Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Khiron Life Sciences Corp (OP: KHRNF )

0.0001 UNCHANGED
Last Price Updated: 2:53 PM EDT, Jun 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Khiron Life Sciences Corp

< Previous 1 2 3 4 5 6 7 Next >
Marijuana Stock Movers For August 15, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
Via Benzinga
Cannabis Stock Gainers And Losers From August 14, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For July 21, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From August 11, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From July 18, 2023
Via Benzinga
Cannabis Stock Movers For August 10, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For July 17, 2023
Via Benzinga
Marijuana Stock Movers For August 9, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From July 14, 2023
Via Benzinga
Marijuana Stock Movers For August 8, 2023
Via Benzinga
Bullish Thursday For Marijuana Stocks - Choom Holdings, EVIO Among Top Gainers
Via Benzinga
Cannabis Stock Gainers And Losers From August 4, 2023
Via Benzinga
Marijuana Stock Movers For July 12, 2023
Via Benzinga
Cannabis Stock Movers For August 3, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From July 11, 2023
Via Benzinga
Marijuana Stock Movers For August 2, 2023
Via Benzinga
Cannabis Movers & Shakers: Latest Appointments From Khiron, MariMed, Equilibria & More
Equilibria Strengthens Women's Wellness With New CSO 
Via Benzinga
Khiron Completes First Phase Of Business Optimization, Reduces Total Direct Labor Headcount By More Than 70% In Its Colombia SAS Subsidiary
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (FSE:A2JMZC) completed its first phase of business optimization in Colombia, to focus on its high-margin B2C business model, centered around its... 
Via Benzinga
Marijuana Stock Movers For August 1, 2023
Via Benzinga
This European City Wants To Legalize Marijuana, New Trial Launches This Summer
The Swiss government is considering legalization of recreational cannabis use and sales in Zurich as part of a new trial set to launch this summer, reported CNBC. 
Via Benzinga
Khiron Snatches First Medical Cannabis Contract With One Of Colombia's Largest Insurance Companies
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN)(Frankfurt:A2JMZC), announced that the new Colombian Government has included plant-based medical cannabis products (i.e., Khiron products) in the... 
Via Benzinga
Cannabis Stock Movers For July 27, 2023
Via Benzinga
Khiron Q3 Revenue Declines 24% Sequentially To $2.5M
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (Frankfurt:A2JMZC) released its financial results for the quarter ended September 30, 2022, revealing revenue of CA$3.4 million ($2.5 million), a... 
Via Benzinga
Khiron Launches Cannabis Flower Products In Switzerland
Khiron Life Sciences Corp. (OTCQX: KHRNF) (TSXV:KHRN) (Frankfurt:A2JMZC), announced its market entry into Switzerland with initial sales of new products and increases its product offerings in Germany... 
Via Benzinga
Cannabis Stock Gainers And Losers From July 26, 2023
Via Benzinga
15 Global Psychedelics Executives To Keep An Eye On In 2022
As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list... 
Via Benzinga
Cannabis Stock Movers For July 24, 2023
Via Benzinga
Cannabis Stock Movers For July 20, 2023
Via Benzinga
Cannabis Stock Movers For July 19, 2023
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.